Evaluation of the prevalence of non-alcoholic fatty liver disease (and steatohepatitis) in patients with type 2 diabetes mellitus

Evaluation of the prevalence of non-alcoholic fatty liver disease (and steatohepatitis) in patients with type 2 diabetes mellitus - Prevalence of NAFLD in type 2 DM

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON29718

Enrollment

1500

Registered

2006-07-19

Start date

2006-05-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fatty liver NASH

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All type 2 diabetes mellitus patients visiting the outpatient clinic internal medicine of the Sint Lucas Andreas Hospital Amsterdam

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Disturbed liver enzymes (i.e. AP, gammaGt, ASAT and ALAT) Increased hepatic echogenicity (hepatic steatosis)	—

Countries

Netherlands

Outcome results